栄研化学 (4549) バランスシート
時価総額
¥1080.3億
PER
44.6倍
検査薬の製造販売を主な事業とし、中国では栄研生物科技が受託生産と仕入製造販売を手がける企業。
| 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | 2026/03 | |
| 現金同等物 | - | 9,590 | 8,245 | 10,039 | 9,734 | 7,554 | 10,098 | 9,150 | 16,121 | 18,317 | 16,308 | 9,873 | 10,917 |
| 有価証券 | - | - | - | - | - | - | - | 80 | - | - | - | - | - |
| 売掛金 | - | 9,756 | 10,233 | 10,356 | 11,718 | 11,959 | 11,017 | 12,298 | 11,956 | 11,122 | 12,482 | 10,928 | 10,174 |
| 商品及び製品 | - | 3,255 | 3,086 | 3,266 | 3,263 | 3,551 | 4,342 | 4,492 | 4,673 | 4,739 | 4,170 | 4,576 | 4,354 |
| 流動資産合計 | - | 25,285 | 24,627 | 26,983 | 27,197 | 25,852 | 28,903 | 29,983 | 37,039 | 39,217 | 37,851 | 31,532 | 32,011 |
| 有形固定資産 | - | 7,118 | 9,067 | 11,689 | 11,391 | 11,095 | 12,041 | 12,768 | 15,275 | 17,202 | 17,005 | 22,121 | 23,291 |
| 投資有価証券 | - | 443 | 391 | 389 | 423 | 555 | 3,487 | 3,410 | 3,614 | 586 | 597 | 408 | 763 |
| 固定資産合計 | - | 12,610 | 14,639 | 17,269 | 17,968 | 21,427 | 21,418 | 25,701 | 25,473 | 27,058 | 23,799 | 30,840 | 30,260 |
| 総資産 | - | 37,895 | 39,266 | 44,252 | 45,165 | 47,279 | 50,322 | 55,685 | 62,512 | 66,275 | 61,651 | 62,372 | 62,271 |
| 買掛金 | - | 3,964 | 4,136 | 4,346 | 4,434 | 4,148 | 4,586 | 4,044 | 4,495 | 4,685 | 4,648 | 5,251 | 4,838 |
| 一年内返済予定の長期借入金 | - | - | - | - | - | - | - | - | - | - | - | - | 300 |
| 流動負債合計 | - | 9,995 | 10,109 | 12,672 | 11,550 | 10,981 | 11,740 | 12,772 | 12,533 | 12,443 | 11,351 | 14,376 | 14,638 |
| 固定負債合計 | - | 1,260 | 956 | 970 | 1,136 | 1,284 | 1,278 | 1,239 | 4,175 | 4,296 | 4,329 | 4,397 | 3,953 |
| 総負債 | - | 11,255 | 11,065 | 13,642 | 12,687 | 12,265 | 13,018 | 14,012 | 16,708 | 16,740 | 15,680 | 18,773 | 18,592 |
| 利益剰余金 | - | 14,838 | 16,571 | 18,758 | 20,359 | 22,869 | 25,302 | 29,166 | 33,162 | 36,865 | 35,801 | 34,700 | 31,017 |
| 株主資本 | 24,278 | 26,639 | 28,201 | 30,609 | 32,478 | 35,014 | 37,303 | 41,672 | 45,803 | 49,535 | 45,971 | 43,598 | 44,034 |
| 運転資本 | - |